(Q40500151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7705326%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

review article

1 reference

title

Prospects for new hormonal male contraceptives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7705326%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

author name string

D E Cummings

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7705326%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

W J Bremner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7705326%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 December 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7705326%20AND%20SRC:MED&resulttype=core&format=json

Endocrinology and Metabolism Clinics of North America

24 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7705326%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7705326%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7705326%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

893-922

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7705326%20AND%20SRC:MED&resulttype=core&format=json

Testosterone supplementation attenuates the antifertility effects of an LHRH agonist in male rhesus monkeys

24 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Reversible induction of azoospermia in rhesus monkeys by constant infusion of a gonadotropin-releasing hormone agonist using osmotic minipumps

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Attainment and maintenance of azoospermia with combined monthly injections of depot medroxyprogesterone acetate and testosterone enanthate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Reduction of testicular luteinizing hormone/human chorionic gonadotropin receptors by [D-Trp6]-luteinizing hormone releasing hormone in hypophysectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Sperm function in Indonesian men treated with testosterone enanthate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Transdermal testosterone substitution therapy for male hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Gonadotropin-Releasing Hormone and Its Agonist Inhibit Testicular Luteinizing Hormone Receptor and Steroidogenesis in Immature and Adult Hypophysectomized Rats*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Differential effects of FSH and testosterone on the maintenance of spermatogenesis in the adult hypophysectomized rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Testosterone selectively increases serum follicle-stimulating hormonal (FSH) but not luteinizing hormone (LH) in gonadotropin-releasing hormone antagonist-treated male rats: evidence for differential regulation of LH and FSH secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Hormonal effects of GnRH agonist in the human male: II. Testosterone enhances gonadotrophin suppression induced by GnRH agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Does constant infusion of gonadotropin-releasing hormone agonist lead to greater suppression of gonadal function in man than its intermittent administration?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Mechanisms of gonadotropin-releasing hormone agonist action in the human male

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Treatment of complicated benign prostatic hyperplasia with LHRH-analogues in aged patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Conformational analysis of a highly potent dicyclic gonadotropin-releasing hormone antagonist by nuclear magnetic resonance and molecular dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Influence of testosterone substitution on sperm suppression by LHRH agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Testicular GnRH receptors--characterization and localization on interstitial tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Which testosterone replacement therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Absence of gonadotropin-releasing hormone receptors in human gonadal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Direct inhibition of testicular function by gonadotropin-releasing hormone: mediation by specific gonadotropin-releasing hormone receptors in interstitial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Randomized clinical trial of testosterone replacement therapy in hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Persistence of Complete Spermatogenesis in the Presence of Low Intratesticular Concentrations of Testosterone*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Combined treatment with an LHRH agonist and testosterone in man. Reversible oligozoospermia without impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

A Prospective, Placebo-Controlled Study of the Luteinizing Hormone-Releasing Hormone Agonist Leuprolide as Treatment for Patients with Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Sperm suppression with monthly injections of medroxyprogesterone acetate combined with testosterone enanthate at a high dose (500 mg)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Epidemiology of prostatic cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Clinical trial with levo-norgestrel and testosterone oenanthate for male fertility control

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effects of a potent LHRH-agonist on the pituitary gonadal axis with and without testosterone substitution

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. II. High initial dose

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Transient reduction in serum HDL-cholesterol following medroxyprogesterone acetate and testosterone cypionate administration to healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The influence of androgens, estrogens and related steroids on serum lipids and lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effect of a GnRH analogue (leuprolide) on benign prostatic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The effect of salicylazosulphapyridine (sulphasalazine) on male fertility. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Use-effectiveness of the condom in a selected family planning clinic population in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Pharmacokinetics and pharmacodynamics of testosterone pellets in man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effects of testosterone and dihydrotestosterone on spermatogenesis, rete testis fluid, and peripheral androgen levels in hypophysectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The Stimulatory and Down-Regulatory Effects of a Gonadotropin-Releasing Hormone Agonist in Man*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Pituitary desensitization and the regulation of pituitary gonadotropin-releasing hormone (GnRH) receptors following chronic administration of a superactive GnRH analog and testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Pituitary receptor site blockade by a gonadotropin-releasing hormone antagonist in vivo: mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Male contraception; synergism of gonadotropin-releasing hormone analog and testosterone in suppressing gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Gonadotropin-releasing hormone analog and testosterone synergistically inhibit spermatogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effect of long‐term oral testosterone undecanoate treatment on prostate volume and serum prostate‐specific antigen concentration in eugonadal middle‐aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Extrapituitary Actions of Gonadotropin-Releasing Hormone*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Extra-pituitary inhibition of testicular function by luteinising hormone releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Restoration of spermatogenesis by high levels of testosterone in hypophysectomized rats after long-term regression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Response of the benign hypertrophied prostate to treatment with an LHRH analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Attitudes of men toward contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Health is a sustainable state

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence. Correlation with plasma testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effects of norgestrel and ethinyloestradiol ingestion on serum levels of sex hormones and gonadotrophins in men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Clinical trial of 19-nortestosterone-hexoxyphenylpropionate (Anadur) for male fertility regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Prolonged treatment with the GnRH analogue buserelin does not affect alpha-subunit production by the pituitary gonadotroph

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effect of testosterone propionate on the prostate gland of patients over 45

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effect of LH-RH analogue in patients withbenign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effect of continuous infusion of a low dose of GnRH antagonist on serum LH and testosterone concentrations, spermatogenesis and semen quality in the rhesus monkey (Macaca mulatta).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Influence of Continuous Gonadotropin-Releasing Hormone (GnRH) Agonist Treatment on Luteinizing Hormone and Testosterone Secretion, the Response to GnRH, and the Testicular Response to Human Chorionic Gonadotropin in Male Rhesus Monkeys*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Maintenance of complete but quantitatively reduced spermatogenesis in hypophysectomized monkeys by testosterone alone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Testosterone can initiate spermatogenesis in an immature nonhuman primate, Macaca fascicularis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Is high dosage testosterone an effective male contraceptive agent?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Modulation of pulsatile gonadotropin secretion by testosterone in man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Endocrine control of human spermatogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Treatment of Benign Prostatic Hypertrophy by a Long-Acting Gonadotropin-Releasing Hormone Analogue: 1-Year Experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Prevalence of contraceptive use: trends and issues

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Testosterone Concentrations in Testes of Normal Men: Effects of Testosterone Propionate Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Male attitudes towards family planning in Khartoum, Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Clinical trial with testosterone undecanoate for male fertility control

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The changing attitude and practice of men regarding family planning in Lagos, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Inhibition of spermatogenesis in the rat by treatment with [D-Ala6, Des-Gly-NH210] LHRH ethylamide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

High affinity GNRH binding to testicular membrane homogenates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Comparison of biological effects of a sustained delivery system and nonencapsulated LH-RH antagonist SB-75 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Heterogeneity of sperm density profiles following 20-week therapy with high-dose LHRH analog plus testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Pharmacokinetics and pharmacodynamics of a new long-acting androgen ester: maintenance of physiological androgen levels for 4 months after a single injection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Lack of a direct effect of gonadotropin hormone-releasing hormone agonist on human testicular steroidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Testicular histology following chronic gonadotropin-releasing hormone agonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Testosterone maintains pituitary and serum FSH and spermatogenesis in gonadotrophin-releasing hormone antagonist-suppressed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effects of chronic treatment with a potent luteinizing hormone releasing hormone agonist on serum luteinizing hormone and steroid levels in the male rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Antireproductive effects of a potent gonadotropin-releasing hormone antagonist in the male rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effect of a potent GnRH antagonist and testosterone propionate on mating behavior and fertility in the male rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effects of cyproterone acetate on reproductive functions in normal human males

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Long term effects of administration of a gonadotropin-releasing hormone superagonist analog in men with prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Absence of a direct inhibitory effect of the gonadotropin-releasing hormone (GnRH) agonist D-Ser (TBU)6, des-Gly-NH2(10) GnRH ethylamide (Buserelin) on testicular steroidogenesis in men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Male contraception involving testosterone supplementation: possible increased risks of prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Ac-D-NAL(2)1,4FD-Phe2,D-Trp3,D-Arg6-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Reversible azoospermia induced by the anabolic steroid 19-nortestosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effects of endogenous sex steroids on serum lipoproteins and postheparin plasma lipolytic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Active immunization with follicle-stimulating hormone for fertility control: a 4 1/2-year study in male rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effect of chronic administration of testosterone enanthate on sperm production and plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels: a preliminary evaluation of a possible male contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Testosterone enanthate a possible reversible male contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Suppression of human spermatogenesis by depot androgen: Potential for male contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Contrasting effects of testosterone and stanozolol on serum lipoprotein levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Suppression of androgen production by D-tryptophan-6-luteinizing hormone-releasing hormone in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

4 Local control systems within the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Residual sperm function in oligozoospermia induced by testosterone enanthate administered as a potential steroid male contraceptive.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Prostate-specific antigen and prostate gland size in men receiving exogenous testosterone for male contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Effect of depot medroxyprogesteroneacetate and testosteroneoenanthate on serum lipoproteins in man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Use of low-dosage oral cyproterone acetate as a male contraceptive.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Exogenous gonadotrophin-releasing hormone (GnRH) stimulates LH secretion in male monkeys (Macaca fascicularis) treated chronically with high doses of a GnRH antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Sustained inhibition of sperm production and inhibin secretion induced by a gonadotrophin-releasing hormone antagonist and delayed testosterone substitution in non-human primates (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

New injectable testosterone ester maintains serum testosterone of castrated monkeys in the normal range for four months

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Suppression of spermatogenesis in a nonhuman primate (Macaca fascicularis) by concomitant gonadotropin-releasing hormone antagonist and testosterone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Contraceptive efficacy of testosterone-induced azoospermia in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The role of follicle stimulating hormone in testicular function of the mature rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

Suppression of sperm function by depot medroxyprogesterone acetate and testosterone enanthate in steroid male contraception.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930074-4

7 January 2021

10.1016/S0889-8529(18)30074-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7705326%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference